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Neonatal corticosterone mitigates 
autoimmune neuropsychiatric 
disorders associated with 
streptococcus in mice
Simone Macrì  1, Chiara Spinello1, Joanna Widomska2, Roberta Magliozzi4,5, 
Geert Poelmans3, Roberto William Invernizzi6, Roberta Creti7, Veit Roessner8,  
Erika Bartolini9, Immaculada Margarit9, Jeffrey Glennon2 & Giovanni Laviola1
Increased glucocorticoid concentrations have been shown to favor resilience towards autoimmune 
phenomena. Here, we addressed whether experimentally induced elevations in circulating 
glucocorticoids mitigate the abnormalities exhibited by an experimental model of Pediatric 
Autoimmune Neuropsychiatric Disorders Associated with Streptococcus (PANDAS). This is a 
pathogenic hypothesis linking repeated exposures to Group-A-beta-hemolytic streptococcus (GAS), 
autoantibodies targeting selected brain nuclei and neurobehavioral abnormalities. To persistently 
elevate glucocorticoid concentrations, we supplemented lactating SJL/J mice with corticosterone 
(CORT; 80 mg/L) in the drinking water. Starting in adolescence (postnatal day 28), developing 
offspring were exposed to four injections - at bi-weekly intervals - of a GAS homogenate and tested 
for behavioral, immunological, neurochemical and molecular alterations. GAS mice showed increased 
perseverative behavior, impaired sensorimotor gating, reduced reactivity to a serotonergic agonist and 
inflammatory infiltrates in the anterior diencephalon. Neonatal CORT persistently increased circulating 
glucocorticoids concentrations and counteracted these alterations. Additionally, neonatal CORT 
increased peripheral and CNS concentrations of the anti-inflammatory cytokine IL-9. Further, upstream 
regulator analysis of differentially expressed genes in the striatum showed that the regulatory 
effect of estradiol is inhibited in GAS-treated mice and activated in GAS-treated mice exposed to 
CORT. These data support the hypothesis that elevations in glucocorticoids may promote central 
immunomodulatory processes.
Neonatal experiences persistently adjust individual adaptation towards future challenges1. While adverse events 
may relate to an increased risk of pathology2, stimulating neonatal conditions may favor resilience towards future 
environmental insults3. Although these considerations originally pertained to emotional4 and cognitive5 domains, 
they have been recently extended to the immune system. For example, Bakker and collaborators6 observed that 
neonatal dexamethasone administration – exerting a long-term reduction of corticosterone reactivity – increased 
individual susceptibility to an experimental autoimmune disease in rats. Meagher et al.7 reported that brief 
(15-min/day) and long (180-min/day) maternal separations during the first two weeks of life increased vulnera-
bility to acute Theiler’s virus infection7. Importantly, also in this study, exposure to neonatal stressors resulted in a 
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blunted activity of the hypothalamic-pituitary-adrenocortical (HPA) axis. These data support the hypothesis that 
experimental interventions capable of reducing corticosterone reactivity to stressors may potentiate autoimmune 
responses8. Likewise, experimentally-induced increases in corticosterone reactivity have been reported to favor 
resilience towards autoimmunity in experimental allergic encephalomyelitis (EAE). Specifically, Levine and col-
laborators exemplified the bimodal regulatory role of corticosteroids on individual reactivity to autoimmunity by 
showing that stress suppresses9 and adrenalectomy potentiates10 vulnerability to EAE.
Epidemiological, clinical and preclinical data support the notion that autoimmune phenomena consti-
tute a vulnerability factor in the onset of psychiatric disturbances. Swedo and colleagues coined the acronym 
PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus) to define a series 
of motor disturbances in which repeated exposures to bacterial (Group-A β-Hemolytic Streptococcus, GAS) 
infections are causally linked to symptoms11. Besides its pediatric onset, the defining criteria of PANDAS include 
the temporal proximity of neurological disturbances and GAS infections, recurrent abnormal behaviors, and 
remitting-relapsing presence of obsessive-compulsive symptoms and/or tics11. A proof of principle of these patho-
logical sequelae has been obtained through several independent preclinical studies12–14. Hoffman et al. observed 
that repeated exposures to GAS homogenate resulted in locomotor alterations associated with increased IgG 
antibody deposits in deep cerebellar nuclei. We recently reported that in the long term, an analogous treatment 
resulted in increased repetitive behaviors, impaired sensorimotor gating, and inflammatory processes in the ros-
tral diencephalon14. Tourette’s Syndrome (TS) and Obsessive Compulsive Disorder (OCD) have been proposed 
to constitute instances of PANDAS: while several studies reported the presence of elevated concentrations of 
anti-streptococcal antibody titers in TS patients15, Orlovska et al.16 demonstrated that streptococcal infections 
relate to an increased risk of OCD in a Danish nationwide study. Both TS and OCD have been associated with 
alterations at the level of the basal ganglia17.
Here, we addressed through a longitudinal study (see Fig. 1 for the study outline) conducted in mice whether 
neonatal stress may modulate individual susceptibility to PANDAS14. We thus tested the prediction that neonatal 
CORT administration – mimicking sustained chronic stress – mitigates behavioral, immunological and neuro-
chemical abnormalities in SJL mice repeatedly exposed to GAS between late infancy and adulthood. To elucidate 
the molecular mechanisms underlying the observed phenotypic alterations, we performed RNA sequencing of 
the striatum, the main component of the basal ganglia that is typically affected in PANDAS17.
Results
Physiological indicators of the efficacy of experimental treatments. Neonatal CORT admin-
istration increases circulating CORT concentrations in the short- and long-term. Hair CORT concentrations 
at weaning were significantly elevated in CORT offspring compared to WATER controls (neonatal treatment: 
F(1,21) = 4,839, p = 0,0392, see Fig. 2a). An analogous increment in CORT concentrations was also observed in 
adulthood (see Fig. 2b), irrespective of GAS administration, when we evaluated serum basal CORT concentra-
tions (neonatal treatment: F(1,32) = 4,611, p = 0,0394, see Fig. 2b).
Repeated GAS exposures elicit the production of anti-GAS antibodies. Western Blot analyses demonstrate that 
sera from GAS-treated mice recognized specific GAS proteins and suggest that CORT administration did not 
influence this response (see Fig. 2c).
Figure 1. Experimental design: Timing of the neonatal treatment and of the injections, expressed in weeks, 
and the experimental procedures performed with two different and independent batches of mice. After 
corticosterone administration during the neonatal phase (postnatal days, PND, 1–10), mice received 5 
injections of GAS homogenate or Phosphate Buffer Saline (PBS), formulated with the indicated adjuvants 
(CFA = Complete Freund’s adjuvant; IFA = Incomplete Freund’s adjuvant). At sacrifice, we collected: in Batch 
I, plasma samples for antibody and cytokine determination and brain samples for immunohistochemistry; in 
Batch II, we collected brain areas for monoamine determinations and RNA sequencing.
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Behavioral testing. Neonatal CORT administration compensates for the PANDAS-like behavioral abnor-
malities induced by repeated GAS exposures. In the absence of major effects of experimental treatments 
on anxiety-related behaviors, general locomotion, and motor coordination (see Supplementary Results and 
Supplementary Table 1 for details), repeated GAS exposures exerted long-term effects in PANDAS-relevant phe-
notypes. Additionally, precocious exposure to CORT hampered the onset of most of these alterations.
To evaluate the functionality of the serotonergic system, we assessed the behavioral response to a pharmaco-
logical challenge with the 5-HT2a agonist DOI after the fifth GAS injection (week 13). As expected, administra-
tion of DOI resulted in the appearance of head twitch in all experimental subjects. While neither neonatal CORT 
administration nor GAS exposure per se apparently influenced duration (neonatal treatment: F(1,33) = 0,469, 
p = 0,4981; PBS/GAS treatment: F(1,33) = 0,027, p = 0,8699), and frequency (neonatal treatment, F(1,30) = 0,606, 
p = 0,4424; PBS/GAS treatment, F(1,30) = 1,304, p = 0,2626) of head twitch, individual response to DOI varied 
depending on early CORT administration and PBS/GAS treatment (head twitch duration, neonatal treatment x 
PBS/GAS treatment: F(1,33) = 5,237, p = 0,0287; head twitch frequency, neonatal treatment x PBS/GAS treat-
ment: F(1,30) = 5,311, p = 0,0283). Specifically, WATER-GAS mice exhibited reduced head twitch compared to 
WATER-PBS. Furthermore, neonatal CORT administration reduced individual reactivity to DOI in PBS mice. 
Finally, in accordance with our predictions, neonatal CORT administration prevented the effects of GAS admin-
istration (p < 0,05 in post hoc tests, see Fig. 3a).
Sensory integration deficits contribute to the PANDAS phenotype. We thus measured sensorimotor gating 
through PPI after the second (week 7) and fourth injection (week 11). As expected, all subjects showed intact 
PPI (reduced startle reflex in reaction to prepulse plus pulse trials than pulse alone trials). In accordance with 
previous evidence indicating that few GAS exposures are insufficient to induce a pathological phenotype, fol-
lowing the second injection, the percentage of inhibition did not vary among groups (neonatal treatment: 
F(1,31) = 2,116, p = 0,1559; PBS/GAS treatment: F(1,31) = 0,061, p = 0,8061; neonatal treatment x PBS/GAS 
treatment, F(1,31) = 0,611, p = 0,4405). Following the fourth injection, while neither neonatal CORT adminis-
tration nor GAS exposure per se apparently influenced PPI (neonatal treatment: F(1,34) = 0,596, p = 0,4454; PBS/
GAS treatment: F(1,34) = 0,208, p = 0,6512), individual responses varied depending on the interaction between 
early CORT administration and PBS/GAS treatment (neonatal treatment x PBS/GAS treatment: F(1,34) = 13,256, 
p = 0,0009). As expected, GAS administration resulted in impaired PPI in subjects precociously exposed to water. 
Neonatal CORT administration, which per se impaired PPI in PBS mice, prevented the effect of GAS administra-
tion (p < 0,05 in post-hoc tests, see Fig. 3b).
Finally, to test whether GAS exposures and CORT administration influenced the exhibition of perseverative 
behavior, we conducted the T-Maze test after the fourth injection (week 11). On average, experimental sub-
jects showed spontaneous alternations, a natural tendency to alternate between the two arms of the apparatus 
(95% CI 57.15 to 80.35). Such natural tendency, considered an inverse index of perseveration, is variable among 
experimental conditions. In particular, while mice exposed to CORT showed spontaneous alternations (95% 
CI 63.90 to 76.53) mice exposed to GAS treatment did not show spontaneous alternation since their preference 
score did not differ from chance level (95% CI 46.27 to 65.95, see Fig. 3c). Conversely, neonatal corticosterone 
administration mitigated the consequences of GAS treatment whereby CORT-GAS subjects showed a percent-
age of spontaneous alternations higher than chance level (95% CI 50.82 to 71.12, see Fig. 3c). Additionally, GAS 
treatment significantly reduced the percentage of spontaneous alternations compared to WATER-PBS individuals 
Figure 2. (a) Hair corticosterone (CORT) concentrations measured at weaning in control (WATER) and 
CORT-treated subjects (n = 11 per group); (b) Plasma CORT concentrations measured at sacrifice (i.e. two 
weeks after the fifth GAS injection; n = 8–12 per group): log-transformed data were used for the statistical 
analysis; actual concentration data are reported for the sake of clarity. CORT-treated subjects showed increased 
concentrations of CORT both in the short- (weaning) and long-term (adulthood). *p < 0,05 compared to 
respective WATER controls; (c) Western Blot analysis of GAS extracts probed with pooled sera from mice 
treated with GAS homogenates or adjuvant alone as Control, neonatal CORT and GAS homogenates or 
neonatal CORT and adjuvant. Lane 1, Western Blot results after probing with sera of control mice injected with 
four doses of adjuvant alone; lane 2, Western Blot results after probing with sera of mice injected with four doses 
of GAS homogenates; lane 3, Western Blot results after probing with sera of mice injected with four doses of 
neonatal CORT and adjuvant; lane 4, Western Blot results after probing with sera of mice injected with four 
doses of neonatal CORT and GAS homogenates. Lanes have been cropped from different parts of the same gel 
(see Supplementary Fig. 2).
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(F(1,34) = 9,074, p = 0,0049, see Supplementary Fig. 3). With respect to neonatal treatment and its interaction 
with GAS administration, we did not observe significant differences (neonatal treatment: F(1,34) = 0,003, 
p = 0,9559; neonatal treatment x PBS/GAS treatment: F(1,34) = 1, 163, p = 0,2884).
Immune activation in response to experimental treatments. We first analyzed whether GAS expo-
sure resulted in inflammatory processes in the brain and then whether CORT compensated for them. In accord-
ance with our predictions, while GAS injections resulted in visible inflammatory infiltrates in adult subjects, 
neonatal CORT exposure remarkably mitigated this effect (Fig. 4). While CORT-PBS mice and WATER-GAS 
mice were characterized by the presence of inflammation (Fig. 4B,C respectively), WATER-PBS mice and 
CORT-GAS mice did not show inflammatory infiltrates (Fig. 4A,D respectively). Furthermore, the diffused 
microglial activity observed in the mesencephalon of WATER-GAS mice (Fig. 4G) was remarkably reduced 
in CORT-GAS mice (Fig. 4H), and CORT-PBS mice (Fig. 4F), while was absent in CORT-PBS mice (Fig. 4E). 
When we analyzed cytokine activation in the plasma (see Supplementary Table 3 for data on cytokine concen-
trations), we observed that, in the absence of effects due to GAS exposure, CORT administration resulted in 
remarkable increases of IL-9, IL-17, MCP-1, and MIP-1beta (see Supplementary Table 3 for details). We therefore 
evaluated whether inflammatory infiltrates were positive for IL-9, a factor indicative of inflammatory processes. 
Accordingly, we observed a considerable number of IL-9+ cells in the inflammatory infiltrates of CORT-GAS 
(Fig. 4I,L) but not of CORT-PBS mice.
Monoamine measurements. Concentrations of serotonin, dopamine, their metabolites and respective turn-
overs are reported in Supplementary Table 2. In the absence of differences in hippocampus and prefrontal cor-
tex, experimental treatments modulated monoamine concentrations in striatum and hypothalamus. Both CORT 
and GAS reduced striatal concentrations of DOPAC (neonatal treatment: F(1,17) = 12,073, p = 0,0029; PBS/GAS 
treatment: F(1,17) = 4,456, p = 0,0499) and 5HIAA (neonatal treatment: F(1,17) = 9,370, p = 0,0071; PBS/GAS 
treatment: F(1,17) = 6,068, p = 0,0247). Furthermore, neonatal CORT administration reduced absolute concentra-
tions of 5-HT in striatum, although this effect was limited to PBS subjects (neonatal treatment: F(1,17) = 7,239, 
p = 0,0155, p < 0,05 in post-hoc tests). With respect to hypothalamus, GAS administration increased dopa-
mine concentrations only in mice precociously exposed to water and not to CORT (neonatal treatment x PBS/
GAS treatment: F(1,20) = 8,394, p = 0,0089; p < 0,05 in post-hoc tests). Furthermore, CORT treatment signifi-
cantly reduced dopamine turnover (neonatal treatment: F(1,20) = 5,184, p = 0,0339; WATER-PBS = 1,03 ± 0,17, 
WATER-GAS = 0,63 ± 0,04, CORT-PBS = 0,62 ± 0,03, CORT-GAS = 0,69 ± 0,08) and serotonin turnover 
(neonatal treatment: F(1,20) = 6,399, p = 0,0199; WATER-PBS = 0,85 ± 0,05, WATER-GAS = 0,68 ± 0,06, 
CORT-PBS = 0,64 ± 0,03, CORT-GAS = 0,69 ± 0,07) in the hypothalamus. Both treatments did not affect dopa-
mine and serotonin turnover in striatum, prefrontal cortex and hippocampus (see Supplementary table 2 for details).
RNA sequencing and upstream regulator analysis. To unravel the molecular mechanisms potentially 
involved in GAS-mediated effects and CORT-dependent compensatory influences, we performed RNA sequenc-
ing and upstream regulator analysis. All data are reported in Supplementary Table 4 (see Supplementary Results 
and Supplementary Fig. 1 for a Venn diagram illustrating the unique and overlapping differentially expressed 
genes for all comparisons). In Table 1, for the sake of clarity, we only refer to the genes that were differentially 
expressed between WATER-GAS vs WATER-PBS and CORT-GAS vs WATER-GAS. In the Supplementary 
Information, we have provided a detailed and referenced description of our results. Below we give a more succinct 
overview of the most important findings and how they could be tentatively interpreted.
We observed that the regulatory effect of (beta-)estradiol is predicted to be inhibited in GAS mice and 
activated in CORT-GAS mice. Thus, while inhibition of estradiol-dependent regulation may be linked to the 
GAS-dependent impairments, its activation in CORT-GAS subjects may contribute to the mitigating effects of 
CORT. In this respect, the effects of dihydrotestosterone - a metabolite that is converted from testosterone by 
5α-reductase - and fibroblast growth factor 2 (FGF2) - which has a positive effect on motor function and is 
Figure 3. (a) Behavioral response (head twitch) to challenge with DOI (5 mg/kg, i.p., week 13, fifth injection) 
during a single 10-min session. Data are expressed as mean + SEM (n = 8–12 per group); (b) Sensorimotor 
gating measured through PPI (week 11, fourth injection). Average inhibition of the startle reflex to a 120-
dB stimulus following the presentation of a pre-pulse of 67, 70, 73, and 76 dB. Values are expressed as mean 
percentage PPI (%PPI) + SEM (n = 8–12 per group); (c) Perseverative behavior in a T-maze (week 11, fourth 
injection) measured as the percentage of spontaneous alternations (circular symbol) with 95% CI (whiskers). 
The dashed lines represent chance level; (a) CI intersecting the dashed line indicates that percentage of 
alternations was not statistically different from chance.
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upregulated by estradiol and CORT - were also predicted to be inhibited in WATER-GAS mice. Further, estradiol 
activates the HPA-axis, resulting in increased CORT production, reinforcing the observed beneficial effect of 
CORT on GAS-induced behavior. Estradiol also regulates the immune response through modulating the immu-
nologic potency of IgG antibodies that are formed against bacteria such as GAS. In PANDAS, it is thought that 
IgG antibodies produced in response to GAS cross the blood brain barrier and are aimed at specific neuronal 
proteins in the basal ganglia, including receptors for the neurotransmitter dopamine (DA), which is converted 
from its precursor L-dopa. In this respect, it is interesting that our findings indicate that signaling dependent 
on both DA and L-dopa is dysregulated in CORT-exposed GAS mice. Furthermore, IgG-dependent regula-
tion is predicted to be inhibited in CORT-exposed GAS mice and both estradiol and CORT increase the striatal 
release of DA, which further implies that increased estradiol signaling mediates the beneficial effect of CORT on 
GAS-induced behavior through both attenuating the IgG response and increasing DA-dependent regulation.
In addition to estradiol, signaling involving two extracellular hormones - i.e., luteinizing hormone (LH) and 
leptin (LEP) - is modulated by exposing GAS mice to CORT. LH is secreted by the pituitary gland and acti-
vates the production of sex hormones, including estradiol and testosterone. Interestingly, estradiol upregulates 
LH expression while its secretion is decreased by dihydrotestosterone, DA and interleukin-2 (IL-2). IL-2 is a 
pro-inflammatory cytokine that activates the immune response, is downregulated by beta-estradiol and increased 
in expression following IgG-mediated GAS infection. As LH-dependent regulation is predicited to be activated 
in CORT-exposed GAS mice while regulation downstream of IL-2 is presumably inhibited in these animals, it 
follows that CORT attenuates the immune response by promoting and counteracting signaling downstream of 
LH and IL-2, respectively. LEP, a hormone with multiple functions including appetite regulation, is predicted to 
be inhibited in CORT-treated GAS mice, which fits with the finding that CORT downregulates LEP expression. 
Further, dihydrotestosterone and beta-estradiol upregulate and downregulate LEP expression, respectively. In 
addition, LEP inhibits the release of DA, which fits with the finding that in CORT-treated GAS mice, the effect 
of LEP is inhibited while DA-dependent signaling is activated. Interestingly, LEP also plays a pro-inflammatory 
role through increasing IL-2 production, which suggests that the anti-inflammatory effect of CORT on GAS mice 
could be mediated at least in part by inhibiting LEP-dependent regulation.
Lastly, our findings point towards two proteins that represent potential targets for developing novel treatments 
of PANDAS, i.e., IKBKB and TREM1. IKKbeta (IKBKB) is a cytoplasmic kinase that is predicted to be inhibited 
Figure 4. Neuropathology assessment of microglia activity in mice brains. H&E staining shows the presence 
of inflammatory infiltrates in the white matter of the rostral diencephalon of a representative CORT-PBS 
mouse (B) and a WATER-GAS mouse (C) not detected in WATER-PBS mice (A) and CORT-GAS mice (D). 
The presence of Iba1+ microglia activity - diffusely present in WATER-GAS mice (G)- was rarely observed in 
CORT-PBS mice (F) and CORT-GAS mice (H), and was mainly detected associated with small, periventricular 
inflammatory infiltrates. Iba1+ microglia activity was not detected in WATER-PBS mice (E). A considerable 
number of IL-9+ cells were observed in the inflammatory infiltrates persisting in different regions of the brains 
of CORT-GAS mice (I,L). The arrow in H indicates the area in serial brain sections where increased density of 
IL-9+ cells was detected. (Original magnification: 5x (B,D), 10x (A,C,E,F,G,L), 20x (H,I).
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in CORT-exposed GAS mice and activates NF-kappaB, a pro-inflammatory transcription factor that is an impor-
tant regulator of innate immunity. Furthermore, both glucocorticoids such as CORT and estradiol negatively 
regulate the activity of IKBKB. In addition, IKBKB upregulates IL-2 expression. Moreover, the transmembrane 
protein TREM-1 is a receptor for GAS and positively mediates the GAS-induced inflammatory response, which 
fits with our finding that CORT exposure leads to an inhibition of TREM-1-dependent regulation in GAS mice. 
Given the findings for IKBKB and TREM1, we would offer that drugs inhibiting or reducing the function of both 
proteins could be further developed as novel PANDAS treatments (see below).
Discussion
In accordance with our previous observations14, while two streptococcal injections failed to induce substantial 
abnormalities, four or more exposures altered behavioral, neurochemical, and immuno-histological parameters 
analogous to those identified in PANDAS patients. Furthermore, as predicted3, neonatal CORT administration 
compensated for most of the GAS-induced abnormalities. These effects co-occur with modifications in HPA 
Upstream Regulator
WATER-GAS vs 
WATER-PBS (1)
CORT-GAS vs 
WATER-GAS (2) Target genes
Chemicals - endogenous mammalian
beta-estradiol −1,97 2,47
(1): Btg2, Cbl, Cshl1, Enpp2, Fos, Inpp5j, Sdc3, Sema3b, Srd5a1, Tnnt3; 
(2): Adm, Bcat1, Bmp2, Calb1, Ccng1, Cdkn2b, Chgb, Ctps1, Dlg2, 
Fgf9, Fmo1, Fnbp1, Fzd2, Gab2, Gsk3b, Hsd17b12, Ier2, Insl3, Lhcgr, 
Lmcd1, Mapt, Mpz, Myh3, Nedd4l, Nkx2–1, Notch3, Pak5, Pdap1, 
Pitpna, Ptgds, Pttg1, Pxdn, Pycr1, Pygl, Qsox1, Rapgef6, Slc38a2, 
Smad3, Snap25, Sstr4, Tgfb3, Thrsp, Timp3, Tpo, Trib1, Vav3, Zyx
butyric acid — 2,16 Calb1, Ccng1, Col5a2, Gli3, Ly6e, Myh3, Nfatc4, Oas2, Ptgds, Pygl, Serpine1, Timp3, Uqcrq
dihydrotestosterone −1,95 — Btg2, Elovl7, Fos, Sdc3, Slc7a7, Srd5a1
dopamine — 1,63 Adra2c, Bcl2l2, Gprc5b, Ncf1, Ppp2r2a, Scn1b, Scn9a
L-dopa — −4,59
Adra2c, Ajap1, C1qtnf12, C2cd2l, Cbr3, Cdc42ep2, Csmd3, Cyld, Dgki, 
Dlg2, Grid2, Kcne5, Klf16, Mpp6, Nedd4l, Per2, Plekha2, Ppp2r2a, 
Ptprd, Rell1, Reln, Slc38a2, Sorcs2, Wdr17, Zfhx3
oleic acid — −2,00 Ncf1, Npc1l1, Serpine1, Thrsp
Complexes
IgG — −2,24 Adm, Cdkn2b, Csnk2b, Ier2, Serpine1
LH — 2,00 Actn1, Btc, Gprc5b, Insl3, Lhcgr, Snap25, Thbs2, Trib1
IL-2 — −1,76 Bmp2, Card9, Ccng1, Ccr6, Cmklr1, Csf2rb, Csrnp1, Ctps1, Dapk2, Gcnt1, Ly6e, Pus1, Tnfrsf4
Enzymes
CASZ1 — −1,96 Acan, Myh3, Nefl, Tgfb3
EGLN1 — −1,98 Acan, Adm, Cdkn2b, Tgfb3
TGM2 — 1,91 Acan, Csrnp1, Dapk2, Ifit2, Ly6e, Mpp6, Oas2
Growth Factors
FGF2 −1,93 — Btg2, Enpp2, Fos, Prkce, Ptma (Includes Others)
INHBA — −2,34 Actn1, Bmp2, Calb1, Cdkn2b, Edar, Lhcgr, Nkx2–1, Pcdh9, Serpine1, Vav3
LEP — −2,16 Cps1, Dffa, Gsk3b, Insl3, Ncf1, Per2, Pln, Rfx1, Serpine1, Snap25, Thrsp, Timp3
Kinases
IKBKB — −1,98 Bmp2, Cdh13, Timp3, Tnfrsf4
Transcription Regulators
KMT2A — 2,00 Gcnt4, Pigz, Trib1, Zmat4
NKX2–3 — −1,61 Adm, Bmp2, Cd34, Cerk, Cryab, Csrnp1, Ly6e, Srpx2, Tmem158
TP53 — 2,11
Actn1, Apbb2, Ccng1, Col5a2, Col9a1, Cryab, Csmd3, Fmo1, Gsk3b, 
Hs3st1, Kcng1, Kifc1, Me2, Nab1, Ncf1, Otx1, P2rx4, Ptgds, Ptger1, 
Pttg1, Serpine1, Sirt6, Tgfb3, Thbs2, Timp3, Tmem151a, Zyx
TP63 — −1,78 Adm, Bmp7, Ccng1, Cdkn2b, Kcng1, Notch3, Serpine1, Smad3, Smad4, Tgfb3, Timp3
Transmembrane Receptors
TREM1 — −2,45 Cdkn2b, Ifit2, Nedd4l, Nme7, Rhou, Tmem158
Table 1. Upstream regulator analysis - using Ingenuity - of the mRNAs that were differentially expressed 
in GAS-treated mice compared to controls (WATER-GAS vs WATER-PBS) (1) and in GAS-treated mice 
neonatally exposed to CORT compared to GAS-treated mice (CORT-GAS vs water-GAS) (2). All upstream 
regulators are listed with a z-score ≤ −1,50 or ≥1,50 or (see Supplementary Methods), indicating that they 
are inhibited or activated, respectively. The upstream regulators that could be linked to streptococcal/GAS 
infection, CORT exposure and/or OCD/tic disorders are indicated in bold. For each regulator, the downstream 
target genes are listed.
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activity, increased serum protein levels of IL-9 paralleled by IL-9+ microglia in the CNS, and changes in stri-
atal gene expression. These results support the view that the HPA axis contributes to the regulation of immune 
responses ultimately modulating the severity of the abnormal phenotype. Lastly, the analysis of the differentially 
expressed genes in the striatum provides information regarding the potential molecular mechanisms associated 
with the pathogenic effects of repeated GAS exposures and the CORT-mediated compensatory role.
In line with the hypothesis that repeated GAS injections induce PANDAS-like behavioral abnormalities, GAS 
mice exhibited reduced sensorimotor gating and sensitivity to DOI, and increased perseverative behavior. These 
phenotypes constitute the preclinical analog of two of the core symptoms observed in PANDAS: impaired sensory 
integration18 and obsessive-compulsive behaviors11. The possibility that a failure of sensory integration relates to 
OCD traits in children has already been discussed elsewhere19. The relevance of PPI within the field of PANDAS 
has been substantiated by anatomical and pharmacological evidence indicating that sensorimotor gating requires 
an intact cortico-striato-thalamo-cortical (CSTC) circuit, generally affected in PANDAS patients20. Additionally, 
while experimental lesions of the striatal circuit impair PPI in laboratory rodents21, drugs acting on dopaminergic 
transmission modulate PPI in both rodents22 and humans23. WATER-GAS mice also exhibited increased perse-
verative responding in a binary-choice test, in which rodents are requested to spontaneously alternate between 
two choices24. This natural tendency requires an intact prefrontal cortex and dorsal striatum25. Furthermore, 
dopaminergic26 and serotonergic27 drugs have been shown to modulate this capability. The altered integrity of 
the serotonergic system in WATER-GAS mice was supported by a reduced reactivity to the pharmacological 
challenge with DOI and further confirmed by significant reductions in 5-HT and 5HIAA concentrations in the 
striatum. Moreover, in accordance with the hypothesis that anti-GAS antibodies result in central inflammatory 
processes14,28, we detected inflammatory infiltrates and ramified microglia at the level of the rostral diencepha-
lon in GAS mice, thus supporting a role for microglia in autoimmune basal ganglia disorders like TS, OCD and 
PANDAS in general29. One aspect that warrants consideration relates to the fact that our experiments have been 
conducted under animal facility rearing (AFR) conditions and not under specific pathogen free (SPF) conditions, 
which by definition guarantee a higher level of sterility. Therefore, since immune responses may vary depending 
on the pathogens encountered by the organism, we cannot exclude the possibility that our results may have been 
different had the experiments been conducted under SPF conditions. We speculate, however, that rather than 
devaluing our study, this factor may confer additional validity to our results. Specifically, the higher variability of 
pathogens, characteristic of AFR compared to SPF, is hypothesized to introduce an additional source of uncon-
trolled variation in the study. The observation of remarkable effects of GAS administration, despite the presence 
of such unavoidable bias, further strengthens our study whereby it indirectly suggests that the long-term conse-
quences of streptococcus administration are stronger than the background noise associated with AFR-related 
pathogens. Future studies are needed to clarify this aspect.
Predictably, neonatal CORT administration resulted in short- and long-term increases in basal concentrations 
of CORT in developing subjects3. In line with previous studies30, CORT-PBS mice exhibited remarkably reduced 
striatal concentrations of DA, 5HT, DOPAC and 5HIAA. Furthermore, neonatal corticosterone administration 
resulted, in the long-term, in reduced hypothalamic turnover of serotonin and dopamine. Alterations in brain 
monoamines and their turnover have already been reported in adult rodents exposed to different forms of neona-
tal stress30. Furthermore, several authors suggested that variations in brain monoamines in response to neonatal 
stressors may relate to deficits in prepulse inhibition31. Accordingly, monoamine results were functionally par-
alleled by behavioral alterations in PPI and sensitivity to DOI. Lastly, neonatal CORT administration resulted in 
increased levels of interleukin 9 (IL-9), IL-17, MCP1, MIP-1beta and in the presence of inflammatory infiltrates. 
IL-9 is produced by activated Th2 lymphocytes and is active on various immune cells32. In addition to its effect 
on the immune system, IL-9 has been shown to regulate cell differentiation of a hippocampal progenitor cell 
line33. Therefore, it could be hypothesized that the increased IL-9 secretion detected in CORT-PBS mice may 
have a role in immune regulation34. Analogous considerations may be proposed for IL-17, produced by Th17 
lymphocytes, and for which a role in autoimmune disturbances has been identified35. Finally, the CORT depend-
ent elevation in MCP1 and MIP-1beta may have also partly contributed to the compensatory effects of neonatal 
corticosterone administration whereby these chemokines have been shown to play a role in experimental models 
of autoimmunity36.
While both CORT and GAS exerted independent effects, the main finding of the present study resides in 
the modulatory role exerted by the former over the latter9, whereby neonatal CORT mitigated the behavioral 
and immunohistochemical effects of GAS. The autoimmune hypothesis of PANDAS postulates that the behavio-
ral alterations are secondary to inflammatory phenomena at the level of the rostral diencephalon. Accordingly, 
besides mitigating the behavioral alterations, neonatal CORT reduced the inflammatory infiltrates and ramified 
microglia observed in WATER-GAS mice. Furthermore, the rare inflammatory infiltrates detected in CORT-GAS 
subjects contained an elevated number of IL-9+ cells. We propose that the compensatory effects of CORT on CNS 
inflammatory phenomena are related to the organizational long-term increase in circulating corticosteroids9. 
Such increase may act through different pathways potentially inhibiting immune activation, thereby mitigating 
the consequences of autoimmune-regulated phenomena. Alternatively, increased corticosteroids may regulate 
the production of inflammatory cytokines which could, in turn, protect the CNS. Experimental data support 
the latter as all GAS-treated subjects produced similar anti-GAS antibodies irrespective of glucocorticoid expo-
sure. Therefore, we investigated whether CORT modulated the inflammatory intracerebral processes induced 
by repeated exposures to streptococcus. Immunological analyses performed in the serum showed that neonatal 
CORT increased concentrations of IL-9 in adulthood. These peripheral alterations were paralleled by IL-9+ cells 
with microglial morphology in the CNS. The latter may exert an anti-inflammatory role34 and potentially hamper 
the consequences of GAS administration. This finding suggests that the CORT-mediated compensatory effects 
would be associated with the activation of cerebral innate immunity. While current data seem to suggest that the 
compensatory influences of CORT occur via the activation of cytokines, the possibility that CORT modulates the 
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production of antibodies cannot be fully excluded based on the available data. Thus, although Western Blot data 
indicate that the antibody response observed in CORT-GAS mice was indistinguishable from that observed in 
GAS mice, we note that our measure was qualitative, and not quantitative, in nature. Thus, we cannot exclude the 
possibility that a more detailed investigation shall identify minor between-group differences in antibody response 
to GAS administration. Quantitative investigations are needed to further clarify this aspect.
The upstream regulator analysis of the differentially expressed genes provides insights into the putative molec-
ular mechanisms underlying the phenotypic abnormalities observed in GAS mice and the compensatory role of 
neonatal CORT. Importantly, while GAS exposures inhibited the female sex hormone (beta)-estradiol-mediated 
regulation of gene expression, neonatal CORT compensated for this effect. The hypothesis that estradiol exerts a 
regulatory role is in line with literature showing that estradiol-deficient rodents show decreased PPI37 and develop 
OCD-like behavioral abnormalities38. Additionally, lower estradiol levels have been shown to correlate with 
increased OCD symptoms in men and women39. Furthermore, estradiol has been reported to regulate the indi-
vidual response to bacterial infections40 through a modulation of IgG antibodies41. Individuals with tics and/or 
OCD also have elevated serum IgG against the human dopamine D1 receptor (D1R)42. In addition, while IgG has 
been shown to induce PANDAS symptoms in humans, its depletion from PANDAS patient sera alleviates the 
symptoms13. Thus, the inhibitory effect exerted by CORT on IgG-regulated gene expression in GAS mice may 
partly contribute to its compensatory role. Lastly, in males, estradiol is produced through the conversion of the 
male sex hormone testosterone, which, in turn, is indirectly regulated by CORT43. An involvement of testosterone 
metabolism in regulating the consequences of GAS infection is further suggested by our finding that the effects of 
the testosterone metabolite dihydrotestosterone on gene expression are inhibited in WATER-GAS mice.
Furthermore, we found that CORT negatively regulates effect on gene expression mediated by Leptin 
(LEP), a hormone and growth factor that exerts a proinflammatory role through increasing IL-2 production by 
T-lymphocytes44. Hence, the anti-inflammatory effect of CORT could be mediated in part by an inhibition of 
LEP-dependent regulation. Moreover, the effect of IKKbeta (IKBKB), a kinase activating the proinflammatory 
transcription factor NF-kappaB (NF-kB), was predicted to be inhibited in CORT-GAS mice. IKBKB has been 
proposed to mediate GAS infections and the exhibition of OCD-like symptoms. Accordingly, inactivation of 
Ikbkb in mice has been shown to reduce GAS infections45 and normalize OCD-like behavior46. Lastly, CORT-GAS 
mice were predicted to have a reduced activation of gene expression regulated by TREM1, a receptor for GAS 
directly involved in inflammatory responses47. TREM1 has also been tested and confirmed as a drug target in the 
treatment of GAS-induced48 and other immunity-related disorders49. Further, it was demonstrated that CORT 
treatment significantly decreased the plasma expression levels of TREM-1 in febrile patients with autoimmune 
disease50. Thus, IKBKB and TREM1 represent interesting potential targets for future studies aimed at developing 
novel interventions to treat PANDAS, in that novel drugs could be developed that negatively regulate both targets.
In conclusion, this study provides a proof of principle of the hypothesis that HPA functionality modulates the 
individual response to autoimmune phenomena (Fig. 5). Furthermore, we identified a potential link between neo-
natal experiences and the underlying molecular mechanisms that are involved in alleviating the PANDAS-related 
pathological phenotype.
Methods and Materials
Animals and rearing. All animal experiments have been performed at ISS in compliance with the European 
Directive 2010/63/UE and Italian Legislative Decree 26/14 on laboratory animal protection and experimentation, 
and authorized by the Italian Ministry of Health (Decree Nr. 217/2010-B). Thirty-six female and 18 male SJL/J 
young adult mice, postnatal day (PND) 56 on the day of arrival, were purchased from Charles River, Italy (Calco, 
Lecco, Italy). Four days after arrival, female mice were removed from their cages and housed with a male (two 
females per cage). After 10 days of mating, male mice were removed, dams for which mating was determined 
(N = 22) were housed individually in standard type-1 polycarbonate cages (33.0 × 13.0 × 14.0 cm), and checked 
daily at 11:00 am for delivery (see Supplementary Methods).
Neonatal treatment. On PND0, dams were divided into two groups: control (WATER) dams (N = 11), and 
corticosterone-treated (CORT) dams (N = 11). CORT was supplemented in drinking water between PND1–10 
as described elsewhere30 (see also Supplementary Methods).
Immunization protocol. A GAS homogenate prepared as described elsewhere12,14 was administered 
through five injections interspaced by two weeks, starting on PND28 (see Supplementary Methods). To minimize 
litter effects, we planned not to inject siblings with the same GAS/PBS treatment. However, since litters were not 
perfectly balanced, out of 22 viable litters, we used littermates five times. The experimental population was com-
posed as follows: control (WATER)-PBS, WATER-GAS, CORT-PBS, and CORT-GAS.
Experimental design. The experimental design (See Fig. 1) entailed repeated behavioral testing, blood 
sampling for the evaluation of the immune response to the injection protocol, blood sampling for CORT level 
determination in basal conditions, and brain sampling/sectioning for neurochemical and immunohistochemical 
assays, and RNA sequencing. We conducted the experiments in two batches:
•	 batch 1: WATER-PBS, N = 8; WATER-GAS, N = 8; CORT-PBS, N = 10; CORT-GAS, N = 12.
•	 batch 2: WATER-PBS, N = 5; WATER-GAS, N = 6 mice; CORT-PBS, N = 7; and CORT-GAS, N = 7.
Physiological indicators of the efficacy of experimental treatments. To determine the efficacy 
of CORT and GAS treatments, we quantified the short- and long-term effects of CORT administration on 
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corticosterone concentrations and of repeated exposures to GAS on the formation of antibodies. We thus eval-
uated: CORT concentrations in hair on PND23, and in plasma in adulthood; and anti-GAS antibodies in serum 
samples following the fourth GAS injection (Supplementary Methods for details).
Behavioral testing. The first test battery, performed one week after the second injection (week 7), entailed: 
elevated zero-maze (day 1) to evaluate potential effects on anxiety-like behavior; pre-pulse inhibition (PPI, day 2 
for habituation and day 3 for testing) to demonstrate that GAS affected sensorimotor integration processes char-
acteristic of PANDAS and OCD; and the evaluation of spontaneous locomotion through an automated scoring 
system (day 4). While elevated zero-maze and locomotion were assessed in the animal facility, PPI was conducted 
in a separate testing room.
The same animals were screened one week after the fourth injection (week 11), in a behavioral test battery 
entailing five tests, performed in the following sequence: elevated plus maze, rotarod (to control for potential 
effects of treatments on motor coordination), and PPI habituation on day 1; PPI testing on day 2; t-maze, to 
evaluate repetitive behaviors, (days 3–7); locomotor activity (days 7–8); individual response (exhibition of head 
twitch) to the serotonergic agonist DOI to evaluate the functionality of the serotonergic system. The behavioral 
test procedures are detailed in the Supplementary Methods.
Immune activation in response to experimental treatments. We evaluated inflammatory pro-
cesses in the central nervous system (CNS) through immunohistochemistry and peripheral cytokines in plasma 
Figure 5. Schematic recapitulating the main topics addressed in the current study: etiological hypothesis (a), 
modulatory role of neonatal corticosterone administration (b), and potential molecular mechanisms involved 
(c). Specifically, in panel (a) we exemplified the etiological hypothesis linking streptococcal immunizations, 
antibody response and behavioral abnormalities. In panel (b) we sketched a candidate mechanism through 
which neonatal corticosterone may mitigate the PANDAS-like neurobehavioural abnormalities. In (c) we 
visually represented the main findings from the upstream regulator analysis. The predicted effects of GAS and 
CORT+ GAS are shown for signaling involving estradiol and the other signaling molecules from the analyses 
that are regulated by estradiol.
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samples. For immunohistochemistry, coronal cryosections (10 μm thickness) were cut from whole brains from 
5 CORT-PBS and 5 CORT-GAS treated mice and stored at −80 °C. As previously described14, hematoxylin and 
eosin staining was performed on all the examined brain samples (1 cryosection every 15 cut cryosections) in 
order to assess the presence of potential inflammatory infiltrates and any evident tissue alteration. Air-dried 
cryosections were used for immunohistochemistry assessment of the level of microglia activation (Iba1) and for 
the immunolocalization of TNF and IL-9 cell expression (see Supplementary Methods). Cytokine concentrations 
in the serum were determined through the Bio-Plex Cytokine Assay (23-Plex, Bio-Rad) following the producer’s 
protocol (see Supplementary Methods for details).
Monoamine measurements. To confirm previous evidence that GAS administration alter brain mono-
amines, and further confirm the similarity between our model and PANDAS, we evaluated 5-HT, DA and their 
metabolites, i.e. 5-hydroxyindole acetic acid (5-HIAA), and 3,4-dihydroxyphenylacetic acid (DOPAC) in prefron-
tal cortex, striatum, hippocampus, hypothalamus and cerebellum. These were quantified by a modified method 
of HPLC combined with an electrochemical detector as previously described14. See Supplementary Methods for 
further details.
RNA sequencing. Using RNA sequencing, we quantified total RNA levels in 22 mice (5 WATER-PBS, 5 
WATER-GAS, 6 CORT-PBS and 6 CORT-GAS). Further details are provided in the Supplementary Methods. 
Briefly, the final sets of differentially expressed genes comprised those that were identified as such – fold change 
≥1.2 and P-value < 0.01 – by at least two of the four used methods. The Venn diagram of the final sets of differ-
entially expressed genes for all comparisons was built with Venny (see Supplementary Methods). For genes that 
showed differential expression, upstream regulator analysis was performed using the Ingenuity Pathway Analysis 
software (IPA), version 00.06 (Ingenuity Systems Inc., Redwood City, CA). Further details are provided in the 
Supplementary Methods.
Statistical analyses. Statistical analyses were conducted using the software Statview 5.0 (Abacus Concepts, 
USA). The experimental design entailed two between-subjects factors (neonatal treatment: WATER vs. CORT; 
and PBS/GAS treatment, two levels: PBS vs. GAS) and one within-subject factor (repeated measures with a vari-
able number of levels, depending on the specific parameter). Thus, the experimental model consisted of a 2 (neo-
natal treatment) × 2 (PBS/GAS treatment) × k (repeated measurements) ANOVA for split-plot designs. Tukey’s 
post hoc tests were used for between-group comparisons. Statistical significance was set at p < 0,05. Finally, to 
evaluate whether experimental subjects met the criterion for T-maze paradigm, the observed phenotype has been 
compared to the threshold through one-sample T- tests.
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